An index of frontier and emerging AI labs.
Bio / AI drug discovery
Generative AI analytics for biopharma research. Co-founded by ex-DeepMind senior research scientists Karl Moritz Hermann and Marc Bellemare; launched from stealth August 2024 with ~$11.3M USD seed.
| Name | Reliant AI |
|---|---|
| Space | Bio / AI drug discovery |
| Founded | 2023 |
| Latest valuation | — |
| Stage | — |
| Status | active |
| HQ | Berlin / Montreal |
| Founders | Karl Moritz Hermann, Marc Bellemare, Richard Schlegel |
| Website | https://reliant.ai |
| Careers | — |
| — | |
| X / Twitter | — |
No funding events recorded.
No founders recorded yet. Submit info.
| Date | Type | Title | Source |
|---|---|---|---|
| 2026-06-03 | added | Reliant AI added to tracker | — |
No sources cited.
| Lab | Valuation | Founded |
|---|---|---|
| Enveda | — | 2019 |
| Helical | — | 2024 |
| Insilico Medicine | — | 2014 |
| Isomorphic Labs | >$15B | 2021 |
| Xaira Therapeutics | ~$4B | 2024 |
| insitro | ~$2.5B | 2018 |
| Generate Biomedicines | ~$2B | 2018 |
| Recursion | ~$1.75B (mkt cap) | 2013 |